Comparison of Buserelin to Danazol Therapy in Endometriosis
book-chapter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Antigonadotropin (danazol) in the treatment of endometriosis via openalex
- ANTIGONADOTROPIN (DANAZOL) IN THE TREATMENT OF ENDOMETRIOSIS via openalex
- Comparison of the histological appearance of human endometrium and endometriotic tissue obtained simultaneously via openalex
- Dynamic tests of hypothalamic and pituitary function in women treated with danazol via openalex
- Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women via openalex
- Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis via openalex
- Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
- Erste Ergebnisse bei der Behandlung der Endometriose mit dem LH-RH-Analogon Buserelin* via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Hormonal effects of danazol and medical oophorectomy in endometriosis. via openalex
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- Luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- Medical Management of Endometriosis via openalex
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist via openalex
- SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELIN via openalex
- The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women via openalex
- Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis. via openalex
- The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian Hormones via openalex
- The use of newer progestins in the treatment of endometriosis via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W2416779647 via openalex
- W1997894565 via openalex
- W2223229280 via openalex
- W2298851384 via openalex
- W2014486464 via openalex
- W2346704459 via openalex
- W2408619637 via openalex
- W2410955081 via openalex
- W170259557 via openalex
- W2415755045 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK